Cargando…

Cardiac involvement in light chain amyloidosis: a case report

Detalles Bibliográficos
Autores principales:	Li, Jing, Wang, Hong-Yan, Bian, Ning, Xu, Ru-Yi, Hua, Can, Niu, Shao-Li, Gan, Zhuo-Kun, Wang, Qing, Tian, Hai-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2020
Materias:	Letter To The Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338934/ https://www.ncbi.nlm.nih.gov/pubmed/32670367 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.06.007

Ejemplares similares

Multiorgan involvement by amyloid light chain amyloidosis
por: Li, Guoliang, et al.
Publicado: (2019)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Light chain cardiac amyloidosis in a nonagenarian
por: Takahashi, Koji, et al.
Publicado: (2022)

Nomogram Model for Dynamic and Individual Prediction of Cardiac Response and Survival for Light Chain Amyloidosis in 737 Patients With Cardiac Involvement
por: Li, Yang, et al.
Publicado: (2021)

Light-chain cardiac amyloidosis with neuropathy: a case report
por: Xu, Zhan-Wen, et al.
Publicado: (2015)

Cardiac involvement in heavy and light chain amyloidosis: A case report and literature review
por: Otaka, Yukihiro, et al.
Publicado: (2019)

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
por: Bézard, Mélanie, et al.
Publicado: (2021)

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
por: Stelmach-Gołdyś, Agnieszka, et al.
Publicado: (2022)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Case for diagnosis. Systemic light chain amyloidosis with cutaneous involvement
por: Gontijo, João Renato Vianna, et al.
Publicado: (2017)

Systemic Immunoglobulin Light Chain Amyloidosis Involving the Large Intestine
por: Swaminathan, Renugadevi, et al.
Publicado: (2021)

Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis
por: Wan, Ke, et al.
Publicado: (2017)

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
por: Tahir, Usman A., et al.
Publicado: (2019)

Light Chain (AL) Cardiac Amyloidosis: A Diagnostic Dilemma
por: Abdelazeem, Basel, et al.
Publicado: (2021)

Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls
por: De Michieli, Laura, et al.
Publicado: (2023)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
por: Grogan, Martha, et al.
Publicado: (2017)

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death
por: Warsame, R, et al.
Publicado: (2015)

Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2020)

A Risk Score to Diagnose Cardiac Involvement and Provide Prognosis Information in Patients at Risk of Cardiac Light-Chain Amyloidosis
por: Wu, Yan, et al.
Publicado: (2022)

Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance
por: Li, Rui, et al.
Publicado: (2016)

Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking
por: Li, Rui, et al.
Publicado: (2017)

Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement
por: Seki, Jack T., et al.
Publicado: (2015)

Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report
por: Draghici, Mirela, et al.
Publicado: (2021)

The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvement
por: Zhao, Liang, et al.
Publicado: (2022)

Electrocardiographic parameters and prognosis of renal light chain amyloidosis
por: Li, Huixian, et al.
Publicado: (2020)

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis
por: Yan, Jipeng, et al.
Publicado: (2022)

Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Cardiac magnetic resonance strain imaging in systemic light chain amyloidosis
por: Andre, Florian, et al.
Publicado: (2014)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
por: Donnelly, Joseph P., et al.
Publicado: (2020)

Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis
por: Miyamoto, Masakazu, et al.
Publicado: (2023)

Significant role of magnetic resonance imaging for the diagnosis and evaluation of cardiac amyloidosis in primary light chain amyloidosis
por: Sekiguchi, Yasunobu, et al.
Publicado: (2020)

Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis
por: Dohy, Zsofia, et al.
Publicado: (2022)

Myocardial Biopsy in a History of Light-Chain Amyloidosis Patient With Serial Cardiac Magnetic Resonance Imaging Not Suggestive of Cardiac Involvement
por: Mizutani, Hana, et al.
Publicado: (2019)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
por: Wang, Fangqing, et al.
Publicado: (2023)

Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis
por: Huh, Jin-Young, et al.
Publicado: (2017)

Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis
por: Wechalekar, A D, et al.
Publicado: (2017)

Light-Chain Cardiac Amyloidosis: A Heart With 2 Very Different Ventricles?
por: Barge-Caballero, Gonzalo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_restlm2pnuk7j4plcf5d4gj97l